Log in to search using one of your social media accounts:

Weight Loss After Bariatric Surgery Improves RAWeight Loss After Bariatric Surgery Improves RA
For people with rheumatoid arthritis who are obese, bariatric surgery leads to substantial improvements in disease activity; some were off all medications a year after the procedure. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Symptoms of Chikungunya Virus Mimic Rheumatoid ArthritisSymptoms of Chikungunya Virus Mimic Rheumatoid Arthritis
Chikungunya virus is often accompanied by joint pain that can persist for months or years and has a serum cytokine profile similar to that of patients with seronegative rheumatoid arthritis. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Rheumatoid Arthritis Therapeutics Clinical Trials Market by Region,...
This report provides elemental information and data relating to the clinical trials on Rheumatoid...(PRWeb November 19, 2014)Read the full story at http://www.prweb.com/releases/2014-rheumatoid-arthritis/clinical-trials-review-h2/prweb12338926.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 20, 2014 Category: Pharmaceuticals Source Type: news

More Respiratory Deaths in Rheumatoid Arthritis PatientsMore Respiratory Deaths in Rheumatoid Arthritis Patients
Rheumatoid arthritis increases the risk of dying from any cause, but especially respiratory and cardiovascular disease, new results from the Nurses' Health Study have suggested. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 19, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR
Data Show Vectra DA is Better Predictor of Joint Damage in RA Patients SALT LAKE CITY, Nov. 19, 2014 -- (Healthcare Sales & Marketing Network) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (MYGN), today presented new data t... DiagnosticsMyriad Genetics, Crescendo Bioscience, Vectra DA, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2014 Category: Pharmaceuticals Source Type: news

Five Prime starts dosing patients in FPA008 Phase I trial to treat rheumatoid arthritis
US-based biotechnology firm Five Prime Therapeutics has started dosing in its Phase I clinical trial of FPA008, a monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R), to treat patients with rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - November 18, 2014 Category: Pharmaceuticals Source Type: news

Mayo Clinic researchers: TNF inhibitors may increase cancer risk in the eye
(Mayo Clinic) One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called tumor necrosis factor inhibitors. They act by dampening part of the immune system called tumor necrosis factor. In one of the balancing acts of medicine, the anti-inflammatory action of the drug also increases the risk for other conditions, in this case, a rare form of eye cancer, uveal melanoma. Mayo Clinic researchers make the case and alert physicians in an article in Mayo Clinic Proceedings (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2014 Category: Global & Universal Source Type: news

Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients
Boston — A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 17, 2014 Category: Databases & Libraries Source Type: news

Blood Test Predicts TNF Inhibitor Response in RA PatientsBlood Test Predicts TNF Inhibitor Response in RA Patients
The ratio of interferon (IFN)-beta to IFN-alpha in blood samples from patients with rheumatoid arthritis (RA) can be used to accurately predict response to TNF inhibitors at 12 to 14 weeks. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

The Rheumatoid Arthritis Vital Education Initiative: The Importance of Comparative Effectiveness Studies (RAVE:ICE)
Registration is open for this series of 4 webinars, which is designed for specialty pharmacists. (Source: HSR Information Central)
Source: HSR Information Central - November 14, 2014 Category: Global & Universal Source Type: news

Ablynx to present data on its anti-IL-6R Nanobody, developed in partnership with Abbvie
Ablynx announced that it will present two posters on its novel anti-IL-6R Nanobody®, ALX-0061, at the 2014 American College of Rheumatology (ACR/ARHP) Annual Meeting, which is taking place from 14 to 19 November 2014 in Boston, MA, USA. (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 14, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Rheumatology ACR 2014 ALX-0061 IL-6R Nanobody Latest News rheumatoid arthritis Source Type: news

Rheumatoid Arthritis and Blood Pressure: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, Dr. Eric Matteson comments on a study which found and association between rheumatoid arthritis and erratic blood pressure. To listen, click the link below. RA and Blood Pressure (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 14, 2014 Category: Databases & Libraries Source Type: news

Rheumatoid Arthritis in Moms-to-Be Linked to Premature Births
Low birth weight also more likely, researchers found (Source: WebMD Health)
Source: WebMD Health - November 13, 2014 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis in Moms-to-Be Linked to Premature Births
Low birth weight also more likely, researchers found Source: HealthDay Related MedlinePlus Pages: Health Problems in Pregnancy, Premature Babies, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 13, 2014 Category: Consumer Health News Source Type: news

Moms with rheumatoid arthritis more likely to give birth prematurely
Babies of women with rheumatoid arthritis (RA) or pre-clinical RA -- the period prior to symptoms -- are 1.5 times more likely to be born prematurely in Denmark. Findings indicate that body measurements of the baby at birth were only slightly lower in children exposed to maternal or preclinical RA compared to those with no exposure to the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 13, 2014 Category: Science Source Type: news

Moms with rheumatoid arthritis more likely to give birth prematurely
(Wiley) Researchers from Denmark and the US report that babies of women with rheumatoid arthritis (RA) or pre-clinical RA -- the period prior to symptoms -- are 1.5 times more likely to be born prematurely in Denmark. Findings published in Arthritis & Rheumatology indicate that body measurements of the baby at birth were only slightly lower in children exposed to maternal or preclinical RA compared to those with no exposure to the disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 13, 2014 Category: Biology Source Type: news

Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye
ROCHESTER, Minn. — One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called TNF inhibitors. They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the balancing acts of medicine, the anti-inflammatory action of the drug also increases the risk for other [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - November 13, 2014 Category: Hospital Management Source Type: news

Rheumatoid Arthritis: New Effective and Cheaper Treatment
Rheumatoid arthritis (RA) is a chronic auto-immune disease that causes pain and stiffness in the joints, fatigue, bone damage and, eventually, loss of mobility. RA afflicts around 1% of people in the western world; in Belgium, 80,000 to 100,000 people currently live with the disease. (Source: Disabled World)
Source: Disabled World - November 11, 2014 Category: Disability Tags: Rheumatoid Arthritis Source Type: news

New effective, safe and cheap treatment strategy for rheumatoid arthritis
A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 10, 2014 Category: Science Source Type: news

New effective, safe and cheap treatment strategy for rheumatoid arthritis
(KU Leuven) A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost. Doctoral researcher Diederik De Cock describes the strategy in a new study published in Annals of Rheumatic Diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2014 Category: Global & Universal Source Type: news

Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients
Boston — A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 10, 2014 Category: Databases & Libraries Source Type: news

Psoriasis or rheumatoid arthritis linked to heart risk
(Reuters Health) - Several conditions that stem from a malfunctioning immune system – psoriasis, psoriatic arthritis and rheumatoid arthritis – may create a higher than average risk for heart-related problems and death, a new study finds. (Source: Reuters: Health)
Source: Reuters: Health - November 6, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Drug-Free Remission a Reality in RA?
(MedPage Today) -- Study looks at possibility of absolute drug-free remission after removing all rheumatoid arthritis therapies. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - November 6, 2014 Category: Geriatrics Source Type: news

Lower Doses of Rheumatoid Arthritis Drugs May Work for Some
Title: Lower Doses of Rheumatoid Arthritis Drugs May Work for SomeCategory: Health NewsCreated: 11/5/2014 12:00:00 AMLast Editorial Review: 11/6/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - November 6, 2014 Category: Rheumatology Source Type: news

Lower Doses of Rheumatoid Arthritis Drugs May Work for Some
Study found many patients with early stage disease stayed in remission with less medication (Source: WebMD Health)
Source: WebMD Health - November 5, 2014 Category: Consumer Health News Source Type: news

Lower Doses of Rheumatoid Arthritis Drugs May Work for Some
Study found many patients with early stage disease stayed in remission with less medication Source: HealthDay Related MedlinePlus Pages: Medicines, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 5, 2014 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis: TNF Inhibitors Linked to Less Fatigue Rheumatoid Arthritis: TNF Inhibitors Linked to Less Fatigue
Patients with rheumatoid arthritis report substantial improvement of fatigue after beginning anti-tumor necrosis factor alpha therapy. Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 5, 2014 Category: Rheumatology Tags: Rheumatology News Source Type: news

Biosimilar Drugs Could Save Billions in Health Care
Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation. (Source: Disabled World)
Source: Disabled World - November 3, 2014 Category: Disability Tags: Pharmaceutical Source Type: news

Biosimilar drugs could create billions in health care savings, study finds
(RAND Corporation) The US Food and Drug Administration is expected soon to approve rules for introduction of 'biosimilars,' generic versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis. A new analysis finds that biosimilars could cut spending on biologics in the United States by $44 billion over the next decade, creating savings for patients, health care payers and taxpayers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2014 Category: Global & Universal Source Type: news

Biosimilar Medications Could Create Billions in Health Care Savings
Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade. (Source: RAND)
Source: RAND - November 3, 2014 Category: Health Management Authors: RAND Corporation Source Type: news

In autoimmune diseases affecting millions, researchers pinpoint genetic risks, cellular culprits
Scores of autoimmune diseases afflicting one in 12 Americans -- ranging from type 1 diabetes, to multiple sclerosis (MS), to rheumatoid arthritis, to asthma -- mysteriously cause the immune system to harm tissues within our own bodies. Now, a new study pinpoints the complex genetic origins for many of these diseases, a discovery that may lead to better diagnosis and ultimately to improved treatments. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 29, 2014 Category: Science Source Type: news

The Ghost of Pregnancies Past
For centuries, theologians have grappled with that line in Exodus 20:5, which states: “For I, the Lord your God, am a jealous God, visiting the iniquity of the fathers on the children to the third and fourth generations of those who hate Me.” From a genetic viewpoint, the iniquity of the fathers might occasionally miss its target, only to hit that innocent bystander, Mom.read more (Source: Psychology Today Sex Center)
Source: Psychology Today Sex Center - October 29, 2014 Category: Sexual Medicine Authors: Mark Borigini, M.D. Tags: Child Development Health Self-Help Sex chronic illness chronic pain chronic pain psychology today genes and pregnancy overcoming pain overcoming pain psychology today rheumatoid arthritis risk of rheumatoid arthritis Source Type: news

Ablynx reports positive results from Phase I bioavailability trial of SC ALX-0061
Belgium-based biopharmaceutical firm Ablynx has reported positive results from the Phase I bioavailability trial of the subcutaneous (SC) formulation of its anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases such as rheumatoid arthritis (R… (Source: Drug Development Technology)
Source: Drug Development Technology - October 27, 2014 Category: Pharmaceuticals Source Type: news

Child's Genes Affect Mom's Risk for Rheumatoid ArthritisChild's Genes Affect Mom's Risk for Rheumatoid Arthritis
The fetal cells that circulate in a mother's body can increase her risk for rheumatoid arthritis. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2014 Category: Consumer Health News Tags: Pathology & Lab Medicine News Source Type: news

Diet and Rheumatoid Arthritis DevelopmentDiet and Rheumatoid Arthritis Development
What is the relationship between diet and the risk for developing rheumatoid arthritis? International Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Osteoporosis screening guidelines miss many younger post-menopausal women
To reduce the risk of bone fractures and the complications arising from them, the United States Preventive Services Task force (USPSTF) recommends that all women age 65 and older be tested and treated for low bone mineral density. The task force also recommends that postmenopausal women aged 50 to 64, get bone mineral density screenings if their 10-year probability of suffering a hip, vertebral, humerus or wrist fracture is 9.3 percent or greater, based on the Fracture Risk Assessment Tool. A new UCLA-led study published in The Journal of Clinical Endocrinology & Metabolism, however, finds that the USPSTF strategy...
Source: UCLA Newsroom: Health Sciences - October 22, 2014 Category: Universities & Medical Training Source Type: news

Father of woman's children may determine her risk of rheumatoid arthritis: study
Women may develop rheumatoid arthritis if they have babies with men carrying high risk genes, it has been suggested (Source: Telegraph Health)
Source: Telegraph Health - October 19, 2014 Category: Consumer Health News Source Type: news

Subcutaneous Tocilizumab: A Promising Alternative in Treating Rheumatoid Arthritis
Source: Lippincott’s Bone and Joint Newsletter - October 19, 2014 Category: Orthopaedics Tags: CME Article Source Type: news

Children's genes affect their mothers' risk of rheumatoid arthritis
(American Society of Human Genetics) A child's genetic makeup may contribute to his or her mother's risk of rheumatoid arthritis, possibly explaining why women are at higher risk of developing the disease than men. This research will be presented Tuesday, Oct. 21, at the American Society of Human Genetics 2014 Annual Meeting in San Diego. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 19, 2014 Category: Global & Universal Source Type: news

Roche delivers solid sales growth for the first nine months of 2014
Group sales up 5% at CER, stable in Swiss francs; 4% higher sales in Pharmaceuticals Division, with strong growth of oncology portfolio, as well as Actemra for rheumatoid arthritis and Xolair for asthma and chronic hives; 6% higher sales in Diagnostics Division, driven by strong Professional Diagnostics’ performance (Source: Roche Media News)
Source: Roche Media News - October 16, 2014 Category: Pharmaceuticals Source Type: news

Roche delivers solid sales growth for the first nine months of 2014
Group sales up 5% at CER, stable in Swiss francs; 4% higher sales in Pharmaceuticals Division, with strong growth of oncology portfolio, as well as Actemra for rheumatoid arthritis and Xolair for asthma and chronic hives; 6% higher sales in Diagnostics Division, driven by strong Professional Diagnostics’ performance (Source: Roche Investor Update)
Source: Roche Investor Update - October 16, 2014 Category: Pharmaceuticals Source Type: news

Hand exercises for rheumatoid arthritis
NIHR-funded research published in The Lancet today has found that tailored hand exercises improve the hand function of rheumatoid arthritis patients.Rheumatoid arthritis is a long-term condition that affects 400,000 people in the UK. It causes pain and stiffness in the joints and can greatly affect quality of life. Most people are treated with drugs that... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - October 10, 2014 Category: American Health Source Type: news

RheumShorts: Bone, Infections, and Cardiovascular Risk (CME/CE)
(MedPage Today) -- Seropositive rheumatoid arthritis can ruin trabecular bone. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - October 9, 2014 Category: Geriatrics Source Type: news

Small molecule 'jams the switch' to prevent inflammatory cell death
A small molecule that blocks a form of cell death that triggers inflammation has been discovered by scientists, opening the door for potential new treatments for inflammatory disease such as rheumatoid arthritis, Crohn's disease and psoriasis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 7, 2014 Category: Science Source Type: news

Rheumatoid Arthritis: An Antigenic ChameleonRheumatoid Arthritis: An Antigenic Chameleon
How does smoking contribute to the risk for RA? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Improve a weak immune system with probiotics
(NaturalNews) How do you know if you have a weak immune system? Simply put, frequent colds and flu, slow healing wounds or autoimmune conditions like, rheumatoid arthritis indicate compromised immune function. Thankfully, there is a natural way to strengthen immunity by consuming... (Source: NaturalNews.com)
Source: NaturalNews.com - October 3, 2014 Category: Consumer Health News Source Type: news

Eighty percent of bowel cancers halted with existing medicines
More than 80 percent of bowel cancers could be treated with existing drugs, an international team of scientists say at the conclusion of their study. The study found that medicines called 'JAK inhibitors' halted tumor growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers. Multiple JAK inhibitors are currently used, or are in clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood cancers and myeloproliferative disorders. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 1, 2014 Category: Science Source Type: news

Eighty percent of bowel cancers halted with existing medicines
(Walter and Eliza Hall Institute) An international team of scientists has shown that more than 80 percent of bowel cancers could be treated with existing drugs.The study found that medicines called 'JAK inhibitors' halted tumor growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers. Multiple JAK inhibitors are currently used, or are in clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood cancers and myeloproliferative disorders. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 1, 2014 Category: Cancer & Oncology Source Type: news

The Dance Between The Immune System and Stem Cells
We named it the  immunoLinkTM We have been testing a growing number of Clients with our Quantibody Arrays. Many of of these clients have Autoimmune Disorder Diseases. These range from Rheumatoid Arthritis to Multiple Sclerosis.These arrays are designed to precisely measure factors or markers (proteins) that are dysregulated by these diseases. We measure the levels of these biomarkers in our Clients' Blood serum. The arrays have also been used to measure the levels of markers in plasma and cell culture supernatants.Based on results, we are finding links between immune system and stem cell health. We call this the ...
Source: Neuromics - September 30, 2014 Category: Neuroscience Tags: autoimmune disease G-CSF GM-CSF Human Mesenchymal Stem Cells immune response immunoLink Neural Progenitor Cells Neural Stem Cell Markers Source Type: news

TNF Inhibitors and Breast Cancer RecurrenceTNF Inhibitors and Breast Cancer Recurrence
Dr Jonathan Kay discusses a recent article looking at breast cancer recurrence risk in patients treated with anti-TNF agents for rheumatoid arthritis. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 30, 2014 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news